Inato
Created in 2016
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
142 75 4,802Activities
Technologies
Entity types
Location
3 Imp. de la Planchette, 75003 Paris, France
Paris
France
Employees
Scale: 51-200
Estimated: 78
SIREN
815298468Engaged corporates
13
6 3Added in Motherbase
4 years, 2 months ago
biotech Value proposition
Matching research sites to the right clinical trial protocols, unlocking site potential worldwide.
At Inato, our mission is to bring clinical trials to each and every patient, regardless of who they are or where they live. Today, with 5% of sites running 70% of clinical trials, only patients with privileged access to these sites have an opportunity to participate in trials. We envision a world where it’s so easy to find and apply for the right trials that the other 95% of sites – often community-based research sites – can play a bigger role and accelerate research. By expanding access, we can make clinical trials more accessible, efficient, and inclusive.
That’s why we’ve created a platform that connects global pharmaceutical companies with a broader range of research sites, while ensuring reliable high performance. Our exclusive site profiles, trial application & verification processes, and ongoing support helps sites (at no charge) to get selected and meet enrollment targets, while giving sponsors access to previously untapped patient populations. We’re seeing growing trust in community sites, faster timelines for sponsors and sites, increased patient accessibility, and diversified participation for more inclusive trials.
Drug development is a challenging, intellectually complex, and rewarding endeavor. By working together to bring trial access into communities across the globe, we can more efficiently develop treatments that are safe and effective for everyone.
pharmaceutical industry, Healthtech, Software Engineering, Machine learning, AI, Clinical Research, Clinical Research Sites, and FeasibilityOriginal language
Matching research sites to the right clinical trial protocols, unlocking site potential worldwide.
At Inato, our mission is to bring clinical trials to each and every patient, regardless of who they are or where they live. Today, with 5% of sites running 70% of clinical trials, only patients with privileged access to these sites have an opportunity to participate in trials. We envision a world where it’s so easy to find and apply for the right trials that the other 95% of sites – often community-based research sites – can play a bigger role and accelerate research. By expanding access, we can make clinical trials more accessible, efficient, and inclusive.
That’s why we’ve created a platform that connects global pharmaceutical companies with a broader range of research sites, while ensuring reliable high performance. Our exclusive site profiles, trial application & verification processes, and ongoing support helps sites (at no charge) to get selected and meet enrollment targets, while giving sponsors access to previously untapped patient populations. We’re seeing growing trust in community sites, faster timelines for sponsors and sites, increased patient accessibility, and diversified participation for more inclusive trials.
Drug development is a challenging, intellectually complex, and rewarding endeavor. By working together to bring trial access into communities across the globe, we can more efficiently develop treatments that are safe and effective for everyone.
Unlock access to trials in the community | Inato
Inato matches the right sites to the right clinical research study, globally.
https://inato.com/?utm_source=linkedin&utm_medium=inato-about&utm_campaign=awareness
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Google IT services, Software Development | Google IT services, Software Development | Other 30 Nov 2024 | | |
 Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Nov 2024 | | |
 Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 30 Nov 2024 | | |
 Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 30 Nov 2024 | | |
 Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 9 Oct 2024 | | |
 Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 16 Apr 2024 | | |
 Avolta Finance, Investment Banking | Avolta Finance, Investment Banking | Other 7 Apr 2023 | | |
 Serena Startup accelerator & VC, Venture Capital and Private Equity Principals | Serena Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 25 Jun 2023 | | |
 Cathay Innovation Startup accelerator & VC, Venture Capital and Private Equity Principals | Cathay Innovation Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 31 Mar 2023 | | |
 France Digitale Startup accelerator & VC, Non-profit Organizations | France Digitale Startup accelerator & VC, Non-profit Organizations | Other 6 Dec 2022 | | |